Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002
Clinical trial NCT02044627 · COMPLETED
Trial details
- NCT number
- NCT02044627
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-01-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.